ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China flag China · Delayed Price · Currency is CNY
12.05
+0.02 (0.17%)
Apr 16, 2026, 3:11 PM CST

ChenGuang Biotech Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
368.8794.05479.72434.03351.51
Depreciation & Amortization
183.4166.95152.83144.85130.74
Other Amortization
1.050.20.20.90.2
Loss (Gain) From Sale of Assets
-1.29-4.430.63-1.08-0.1
Asset Writedown & Restructuring Costs
6.77-1.11.3210.91
Loss (Gain) From Sale of Investments
-55.63-12.68-74.02-33.45-30.93
Provision & Write-off of Bad Debts
4.890.110.870.77-1.93
Other Operating Activities
127.9197.1980.74100.2574.9
Change in Accounts Receivable
-8.2462.07135.24-274.17-119.09
Change in Inventory
-391.83-670.57-1,145187.13-435.93
Change in Accounts Payable
-31.41-41.67-211.8176.3190
Operating Cash Flow
212.91-222.81-588.47734.8163.9
Operating Cash Flow Growth
---1049.93%-87.93%
Capital Expenditures
-135.26-149.54-189.2-176.03-280.82
Sale of Property, Plant & Equipment
4.480.020.280.423.58
Divestitures
-0.28----
Investment in Securities
53.04-315.58-336.91-540.91-
Other Investing Activities
69.5224.1577.5620.1212.47
Investing Cash Flow
-8.5-440.95-448.27-696.4-264.76
Long-Term Debt Issued
5,9765,7834,6783,5112,081
Total Debt Issued
5,9765,7834,6783,5112,081
Long-Term Debt Repaid
-5,767-5,088-3,381-3,132-1,278
Total Debt Repaid
-5,767-5,088-3,381-3,132-1,278
Net Debt Issued (Repaid)
208.69695.81,297378.58803.12
Repurchase of Common Stock
--396.53-95.84--
Common Dividends Paid
-159.85-174.05-181.41-143.98-109.77
Other Financing Activities
20.62-21.41276.95-195.55-152.39
Financing Cash Flow
69.45103.81,29739.05540.96
Foreign Exchange Rate Adjustments
-3.62-10.49-6.05-4.94-4.36
Net Cash Flow
270.24-570.46254.0372.51335.75
Free Cash Flow
77.65-372.35-777.67558.78-216.92
Free Cash Flow Margin
1.18%-5.32%-11.32%8.88%-4.45%
Free Cash Flow Per Share
0.16-0.72-1.461.05-0.41
Cash Income Tax Paid
-8.377.269.45-46.55-31.36
Levered Free Cash Flow
-717.4639.79-997.32-131.42-423.74
Unlevered Free Cash Flow
-660.69111.3-945.13-89.42-390.52
Change in Working Capital
-423.06-664.21-1,23187.21-471.4
Source: S&P Global Market Intelligence. Standard template. Financial Sources.